Part,  Chapter, Paragraph

  1    I,     3.  2        |          population increased by about 22%. Increases in population
  2   II,     5.  1.  1    |              ESRD, affecting more than 22% of the incident patients.~
  3   II,     5.  2.  4    |                different age ranges in 22 EU countries.~ ~Table 5.
  4   II,     5.  2.  4    |              continent, estimated that 22% of heart attacks in Western
  5   II,     5.  3.  5    |            Northern Europe (Figure 5.3.22 and Figure 5.3.24) where
  6   II,     5.  3.  5    |           standard) in 2002~Figure 5.3.22. Trends of cervical cancer (
  7   II,     5.  5.Int(21)|       Parliament and of the Council of 22.12.1998, Official Journal
  8   II,     5.  5.  1    |            disorder to vary between 10-22% and projected lifetime
  9   II,     5.  5.  1    |                to 2005. Eur Psychiatry 22(3):146-52.~ ~S G (2005).
 10   II,     5.  5.  3    |           Children) survey showed that 22% of boys and 38% of girls
 11   II,     5.  5.  3    |         Additionally, 36% of girls and 22% of boys feel dissatisfied
 12   II,     5.  5.  3    |        inhabitants, status on February 22, 2008) the calculated prevalence
 13   II,     5.  5.  3    |                2003). Their findings22% of burden could be averted
 14   II,     5.  5.  3    |               autism in each of Wales22 Local Authorities; extensive
 15   II,     5.  5.  3    |                RR of death (95% CI 3.8-22.7) compared with patients
 16   II,     5.  5.  3    |          intense use of informal care (22% of total costs) to help
 17   II,     5.  5.  3    |              indirect costs) represent 22% of the total cost. No reliable
 18   II,     5.  5.  3    |              ascertainment. Neurol Res 22:156-159.~MSTCG (Multiple
 19   II,     5.  5.  3    |          update. Neurological Sciences 22:117-140.~Rose AS, Ellison
 20   II,     5.  5.  3    |             sclerosis. Neurology 26:20-22.~Rothwell PM, Charlton D (
 21   II,     5.  5.  3    |           sclerosis. Neuroepidemiology 22:65-74.~
 22   II,     5.  5.  3    |        Parkinson’s disease. Mov Disord 22 Suppl 17:S343-350.~Global
 23   II,     5.  5.  3    |        Parkinson’s disease. Mov Disord 22(6):804-812.~Mutch WJ, Dingwall-Fordyce
 24   II,     5.  6.  3    |           Europe, just over one-fifth (22%) of the population currently
 25   II,     5.  6.  3    |                categories representing 22.6% of the total cost of
 26   II,     5.  7.  4    |              ESRD, affecting more than 22% of the incident patients.~ ~
 27   II,     5.  7.  7    |           Nephrol Dial Transplant 2007;22:678-80.~Jager KJ, Zoccali
 28   II,     5.  7.  7    |                 Semin Nephrol 2002 Nov;22(6):441-8.~Otero A, Gayoso
 29   II,     5.  7.  7    |                Gen Intern Med 2007 Jul;22(7):1018-23.~Smith DH, Gullion
 30   II,     5.  8.  3    |              and COPD were assessed at 22% and 12% in never-smokers (
 31   II,     5.  8.  4    |             continuous smokers, and to 22% and 12% in never-smokers (
 32   II,     5.  8.  4    |               and phlegm (odds ratio 1.22 compared to males) (Cerveri
 33   II,     5.  8.  7    |             adults. Eur Respir J 2003; 22: 413-417.~ ~Chapman KR,
 34   II,     5.  8.  7    |             years old. Fam Pract 2005; 22: 485-489.~ ~Goodridge D.,
 35   II,     5.  8.  7    |           analysis. Eur Respir J 2003; 22: 809-814.~ ~Jansson SA,
 36   II,     5.  9.  3    |           average physician costs were 22% (of which 75% related to
 37   II,     5. 10.  7    |               the European Union L 75, 22.03.2005, pp. 3334.~htt ~ ~
 38   II,     5. 10.  7    |           Toxicol. 2007 Jul;45(7):1116-22. Epub 2007 Jan 9.~ ~Woods
 39   II,     5. 11.  1    |               common, affecting around 22.533.0% of the European
 40   II,     5. 11.  3    |      Dermatology and Venereology, 2008;22(2):174181.~ ~ ~ ~Although
 41   II,     5. 12.  1    |                over 58/100,000 men and 22/100,000 women in Hungary
 42   II,     5. 12.  3    |          highest rates in 2000-02 were 22.6/100,000 in Romania, followed
 43   II,     6.  3.  1    |              improved surveillance. In 22 diseases the age groups
 44   II,     6.  3.  1    |                 to campylobacteriosis22.3 million, to rotavirus €
 45   II,     6.  3.  3    |             537 cases were reported by 22 countries. The highest incidence
 46   II,     6.  3.  3    |                lowest in Luxembourg (0.22 per 100 000), followed by
 47   II,     6.  3.  4    |             aged over 64 accounted for 22% of the cases overall, while
 48   II,     6.  3.  4    |        important.~ ~In the EU in 2005, 22% of AIDS cases had TB as
 49   II,     6.  3.  5    |             498 cases were reported by 22 countries. The overall incidence
 50   II,     6.  3.  6    |             152 cases were reported by 22 countries but only five
 51   II,     6.  3.  6    |             337 cases were reported by 22 countries. Lithuania (0.
 52   II,     6.  3.  7    |            2004, ranging from 0.1 to 0.22 cases per 100 000. The lowest
 53   II,     6.  3.  7    |                rabies were reported by 22 countries; four of them
 54   II,     7.  3.  4    |                inhabitants in Malta to 22 in Lithuania which indicates
 55   II,     7.  3.  4    |               accidents in the EU27 is 22 per 100,000 residents and
 56   II,     7.  4.  4    |               this age group (Figure 7.22).~ ~Figure 7.22. Sports
 57   II,     7.  4.  4    |               Figure 7.22).~ ~Figure 7.22. Sports practiced at the
 58   II,     8.  1.  3    |          considerable limitations were 22% lower than those of people
 59   II,     8.  1.  5    |         European Commission along with 22 Member States has signed
 60   II,     9            |             between 49% in Austria and 22% in Cyprus (1993 data).~ ~
 61   II,     9            |               use cannabis than girls: 22% and 16%, respectively,
 62   II,     9.  1.  1    |               fetal deaths at or after 22 completed weeks of gestation
 63   II,     9.  1.  1    |               of fetal deaths begin at 22 weeks or 500 g, but that
 64   II,     9.  1.  1    |           after live birth at or after 22 complete weeks of gestation
 65   II,     9.  1.  1    |           after live birth at or after 22 completed weeks gestation
 66   II,     9.  1.  1    |               rates ranged from 6.4 to 22.1 per 1 000 total births
 67   II,     9.  1.  1    |             Perinat Epidemiol 16(1):16-22.~ ~Langer B, Caneva MP,
 68   II,     9.  1.  1    |          maternal age. Hum Reprod 2007;22(5):1264-72.~Luke B, Brown
 69   II,     9.  1.  1    |              Health Stat Q 2004(24):14-22.~Olausson PM, Cnattingius
 70   II,     9.  1.  2    | population-based study. BMJ. 2006 July 22; 333(7560): 177.~MRC Vitamin
 71   II,     9.  2.  4    |             between 49% in Austria and 22% in Cyprus (1993 data).~ ~
 72   II,     9.  2.  4    |               use cannabis than girls: 22% and 16%, respectively,
 73   II,     9.  2.  7    |                 Child Care Health Dev. 22:55-71.~ ~Neumark-Sztainer
 74   II,     9.  2.  7    |              20aspects%20of%20drinking%22 ] (accessed 12.01.07)~ ~
 75   II,     9.  3.  1    |            Care, Health & Development; 22(1): 55-71~ ~Möller-Leimkühler
 76   II,     9.  3.  2    |                Epidemiol 2002;16(1):16-22.~ ~Kramer MS, Seguin L,
 77   II,     9.  3.  2    |          maternal age. Hum Reprod 2007;22(5):1264-72.~ ~Luke B, Brown
 78   II,     9.  3.  2    |              Health Stat Q 2004(24):14-22.~ ~Marret S, Ancel PY, Marpeau
 79   II,     9.  3.  3    |            currently aged 60 to 64 was 22, while for those currently
 80   II,     9.  3.  3    |            usage during the past year, 22.4% of one thousand individuals
 81   II,     9.  3.  3    |                at: htt l (accessed Sep 22, 2006)~Fenton KA, Johnson
 82   II,     9.  5.  3    |                     of bein en by part 22% sai er had thre ed to beat
 83   II,     9.  5.  3    |             found that 26% of boys and 22% of girls in Sweden had
 84   II,     9.  5.  6    |            Care, Health & Development; 22(1): 55-71~ ~Morris M (2004): '
 85  III,    10.  1.  3    |                adolescents. Int J Obes 22:354-362.~Babor TF, Kranzler
 86  III,    10.  1.  3    |                Obes Relat Metab Disord 22 Suppl 2:S22-S29.~Bondy SJ (
 87  III,    10.  1.  3    |             Clin Exp Pharmacol Physiol 22(3):212-216.~Collins JJ,
 88  III,    10.  1.  3    |            Acta Psychiatr Scand 113:13-22.~Szklo M (2000): Confounding
 89  III,    10.  1.  3    |      consumption. Alcohol Clin Exp Res 22(7):285S-298S.~Thompson JC (
 90  III,    10.  2.  1    |       Épidémiologique hebdomadaire. 21-22:198-200 [On-line publication
 91  III,    10.  2.  1    |              2005, while it dropped by 22% in Italy between 1974 and
 92  III,    10.  2.  1    |               EU15, and for one fifth (22%) of the difference between
 93  III,    10.  2.  1    |                year-old adolescents in 22 countries of the EU27 (Currie
 94  III,    10.  2.  1    |              includes 35,955 subjects (22,924 women and 13,031 men)
 95  III,    10.  2.  1    |            found in Portugal (27.1 and 22.1%, boys and girls), Spain (
 96  III,    10.  2.  1    |            organized by EFSA on 21 and 22 March 2006 (EFSA, 2007)
 97  III,    10.  2.  1    |           COLLOQUIUM, Parma, Italy, 21-22 March 2006 [http://www.efsa.
 98  III,    10.  2.  1    |               Official Journal L 052 , 22/02/2001 P. 0019 – 0025.~
 99  III,    10.  2.  1    |               Official Journal L 083 , 22/03/2006 P. 0014 – 0015.~[
100  III,    10.  2.  1    |           healthy lifestyles in Europe 22(1):1-8.~ ~Gennari C (2001):
101  III,    10.  2.  1    |                elderly. Am J Clin Nutr 22: 1-8.~ ~Scientific Committee
102  III,    10.  3.  2    |         chemicals (CMR) - increased by 22% (Eurostat, 2006). The annual
103  III,    10.  3.  2    |           emission of dioxins/furans (-22.5%) into the atmosphere.
104  III,    10.  3.  3    |         represents a great concern. In 22 diseases, the age groups
105  III,    10.  3.  4    |              70%, in United Kingdom by 22% (with a 59% excess in the
106  III,    10.  4.  2    |          Mandate of the PPR Panel (Art 22.6 of EFSA Regulation 178/
107  III,    10.  4.  2    |          Council Directive 95/69/EC of 22 December 1995 laying down
108  III,    10.  4.  2    |        European Communities No. L 338, 22 December 2005. Available
109  III,    10.  4.  2    |       Parliament and of the Council of 22 September 2003 on genetically
110  III,    10.  4.  2    |       Parliament and of the Council of 22 September 2003 concerning
111  III,    10.  4.  2    |               Communities No. L 52/19, 22 February 2001. Available
112  III,    10.  4.  2    |               Communities No. L 83/14, 22 March 2006.~Available at:~htt ~ ~
113  III,    10.  4.  2    |               Decision No. 95/69/EC of 22 December 1995 laying down
114  III,    10.  5.  2    |            countries of the EU (Spain: 22% in urban versus 33% in
115  III,    10.  5.  2    |                21% versus 33%; Greece: 22% versus 29%; but also in
116  III,    10.  5.  2    |             Mortality rates were about 22% higher in cities than in
117  III,    10.  5.  2    |               1992. Thorax, 52(3), 218-22.~ ~Lopez-Abuin JM, Garcia-Criado
118  III,    10.  5.  3    |       Furthermore, 33% of the male and 22% of the female respondents
119  III,    10.  5.  3    |            suffering from backache and 22% complain about muscular
120  III,    10.  6.  1    |            category~ ~In EU 15, almost 22% of the citizens reported
121  III,    10.  6.  1    |            Depression. Health Rep 7:11-22.~ ~Börsch-Supan A, Jürges
122   IV,    11.  1.  6    |              criteria (including 23 or 22% of all hospitals using
123   IV,    11.  6.  4    |               factors included~Austria~22 social security institutions~
124   IV,    11.  6.  4    |       institutions~Each fund allocates~22 funds~No risk pooling across
125   IV,    11.  6.  5    |              Instrument." J Clin Oncol 22: 2000-7.~ ~Busse R, Schreyogg
126   IV,    11.  6.  5    |               Kingdom." Health Affairs 22(3): 134-48.~ ~Masseria C,
127   IV,    12.  1        |               against cancer contained 22 measure, covering the fields
128   IV,    12. 10        |             carried out by dentists,~§ 22 SGB V prevention of dental